Concepedia

Fengyi Weng

FW

Statistics

Publications

5

Citations

98

H-Index

5

Active since

2021

Affiliations

Shanghai University of Traditional Chinese Medicine(Current)

Shuguang Hospital

Fengyi Weng is an author at Shanghai University of Traditional Chinese Medicine specializing in cholestasis pathophysiology, hepatology, and liver disease.

Publications per year

2021–2023

5

Publications

5

Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway

Guochao Song, Fengyi Weng, Bin Zou et al. · Clinical Science · 2023 · 28 citations · Full text

, , +17

Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms

Qian Wang, Guochao Song, Fengyi Weng et al. · Frontiers in Pharmacology · 2022 · 23 citations · Full text

, , +17

Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling

Guochao Song, Bin Zou, Jing Zhao et al. · Journal of Ethnopharmacology · 2023 · 18 citations

, , +13

Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism

Huizong Su, Qian Wang, Yue Li et al. · Frontiers in Pharmacology · 2021 · 17 citations · Full text

, , +17

Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis

Bin Zou, Shuang Zhang, Jing Zhao et al. · European Journal of Pharmacology · 2023 · 12 citations

, , +16

1–5 of 5